Marco Arndt

2.2k total citations
37 papers, 1.7k citations indexed

About

Marco Arndt is a scholar working on Oncology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Marco Arndt has authored 37 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 15 papers in Molecular Biology and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Marco Arndt's work include Peptidase Inhibition and Analysis (17 papers), Neuropeptides and Animal Physiology (8 papers) and Glycosylation and Glycoproteins Research (5 papers). Marco Arndt is often cited by papers focused on Peptidase Inhibition and Analysis (17 papers), Neuropeptides and Animal Physiology (8 papers) and Glycosylation and Glycoproteins Research (5 papers). Marco Arndt collaborates with scholars based in Germany, United States and Croatia. Marco Arndt's co-authors include Uwe Lendeckel, Siegfried Ansorge, Andreas Goette, Christof Huth, Helmut Klein, Christoph Röcken, J. Christoph Geller, Hubert G. Hotz, Birgit Hotz and Heinz-J. Buhr and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Clinical Cancer Research.

In The Last Decade

Marco Arndt

37 papers receiving 1.7k citations

Peers

Marco Arndt
Y Yazaki Japan
Rajeev Mahimkar United States
Aaron J. Donner United States
Yuenian Eric Shi United States
P Wülfing Germany
Bradford A. Young United States
Sandra Mifsud Australia
Y Yazaki Japan
Marco Arndt
Citations per year, relative to Marco Arndt Marco Arndt (= 1×) peers Y Yazaki

Countries citing papers authored by Marco Arndt

Since Specialization
Citations

This map shows the geographic impact of Marco Arndt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Arndt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Arndt more than expected).

Fields of papers citing papers by Marco Arndt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Arndt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Arndt. The network helps show where Marco Arndt may publish in the future.

Co-authorship network of co-authors of Marco Arndt

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Arndt. A scholar is included among the top collaborators of Marco Arndt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Arndt. Marco Arndt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stoyanova, Ani K., Arne Sattler, Nina A. Hering, et al.. (2023). Immune Phenotypic Characterization of a TRAIL-Knockout Mouse. Cancers. 15(5). 1475–1475. 1 indexed citations
2.
Hering, Nina A., Marco Arndt, Johannes C. Lauscher, et al.. (2023). Targeting Interleukin-6/Glycoprotein-130 Signaling by Raloxifene or SC144 Enhances Paclitaxel Efficacy in Pancreatic Cancer. Cancers. 15(2). 456–456. 12 indexed citations
3.
Droeser, Raoul A., et al.. (2023). Muscarinic Acetylcholine Receptor M3 Expression and Survival in Human Colorectal Carcinoma—An Unexpected Correlation to Guide Future Treatment?. International Journal of Molecular Sciences. 24(9). 8198–8198. 2 indexed citations
4.
Hering, Nina A., Marco Arndt, Sefer Elezkurtaj, et al.. (2022). Gp130 is expressed in pancreatic cancer and can be targeted by the small inhibitor molecule SC144. Journal of Cancer Research and Clinical Oncology. 149(1). 271–280. 7 indexed citations
5.
Hering, Nina A., Benjamin Weixler, Raoul A. Droeser, et al.. (2021). Blockage of Cholinergic Signaling via Muscarinic Acetylcholine Receptor 3 Inhibits Tumor Growth in Human Colorectal Adenocarcinoma. Cancers. 13(13). 3220–3220. 21 indexed citations
6.
Hartmann, Lisa, et al.. (2021). Effect of bowel preparation on intestinal permeability and inflammatory response during postoperative ileus in mice. Surgery. 170(5). 1442–1447. 1 indexed citations
7.
Hotz, Birgit, Ulrike Erben, Marco Arndt, H. J. Buhr, & Hubert G. Hotz. (2014). Taurolidine induces epithelial-mesenchymal transition via up-regulation of the transcription factor Snail in human pancreatic cancer cell lines. International Journal of Colorectal Disease. 29(11). 1339–1348. 1 indexed citations
8.
Rybak, S.M., Marco Arndt, Thomas Schirrmann, Stefan Dübel, & John C. Krauss. (2009). Ribonucleases and ImmunoRNases as Anticancer Drugs. Current Pharmaceutical Design. 15(23). 2665–2675. 25 indexed citations
9.
Traub, Frank, Ruth Ladurner, Marco Arndt, et al.. (2008). Intestinal Lipid Absorption Increases Cold Ischemia of the Small Bowel in Rats. Transplantation Proceedings. 40(4). 981–982. 1 indexed citations
10.
Arndt, Marco, Dirk Reinhold, Uwe Lendeckel, et al.. (2006). Specific Inhibitors of Dipeptidyl Peptidase IV Suppress mRNA Expression of DP IV/CD26 and Cytokines. Kluwer Academic Publishers eBooks. 477. 139–143. 1 indexed citations
11.
Lendeckel, Uwe, Thilo Kähne, Dagmar Riemann, et al.. (2006). Review: The Role of Membrane Peptidase in Immune Functions. Kluwer Academic Publishers eBooks. 477. 1–24. 28 indexed citations
12.
Lendeckel, Uwe, et al.. (2006). Modulation of WNT-5At Eexpression by Actinonin: Linkage of APN to the WNT-Pathway?. Kluwer Academic Publishers eBooks. 477. 35–41. 9 indexed citations
13.
Lendeckel, Uwe, Marco Arndt, Alicja Bukowska, et al.. (2005). Synergistic Action of DPIV and APN in the Regulation of T Cell Function. Kluwer Academic Publishers eBooks. 524. 123–131. 17 indexed citations
14.
Lendeckel, Uwe, et al.. (2004). Increased expression of ADAM family members in human breast cancer and breast cancer cell lines. Journal of Cancer Research and Clinical Oncology. 131(1). 41–48. 132 indexed citations
15.
Bukowska, Alicja, Marco Arndt, Carmen Wolke, et al.. (2003). Transcriptional Regulation of Cytosol and Membrane Alanyl-Aminopeptidase in Human T Cell Subsets. Biological Chemistry. 384(4). 657–65. 18 indexed citations
16.
Lendeckel, Uwe, Marco Arndt, Carmen Wolke, et al.. (2002). Inhibition of human leukocyte function, alanyl aminopeptidase (APN, CD13) and dipeptidylpeptidase IV (DP IV, CD26) enzymatic activities by aqueous extracts of Cistus incanus L. ssp. incanus. Journal of Ethnopharmacology. 79(2). 221–227. 14 indexed citations
17.
Lendeckel, Uwe, Marco Arndt, Sabine Wrenger, et al.. (2001). Expression and Activity of Ectopeptidases in Fibrillating Human Atria. Journal of Molecular and Cellular Cardiology. 33(6). 1273–1281. 41 indexed citations
18.
Goette, Andreas, Christoph Röcken, Marco Arndt, et al.. (2000). Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. Journal of the American College of Cardiology. 35(6). 1669–1677. 441 indexed citations
19.
Lendeckel, Uwe, et al.. (1998). Identification of point mutations in the aminopeptidase N gene by SSCP analysis and sequencing. Human Mutation. 11(S1). S158–S160. 5 indexed citations
20.
Lendeckel, Uwe, Thomas Wex, Dirk Reinhold, et al.. (1997). Activation-Dependent Induction of T Cell Alanyl Aminopeptidase and Its Possible Involvement in T Cell Growth. Advances in experimental medicine and biology. 421. 59–66. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026